SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-21-005143
Filing Date
2021-08-03
Accepted
2021-08-03 20:02:27
Documents
1
Period of Report
2021-07-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 17062
  Complete submission text file 0001562180-21-005143.txt   18711
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Issuer) CIK: 0000897448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O AMARIN PHARMA, INC. 1430 ROUTE 6 BEDMINSTER NJ 07921
Business Address
THERO JOHN F (Reporting) CIK: 0001199637 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21392 | Film No.: 211141800